Last updated on May 2017

Gefitinib Long-term Survivor Study


Brief description of study

The primary objective is to describe the genomic profile of long-term survivors, especially to find out potential genomic prognosis and/or predictive factors for gefitinib long-term efficacy as compared to rapid PD patients

Clinical Study Identifier: NCT02932345

Find a site near you

Start Over

Research Site

Shijiazhuang, China
  Connect »